Table 3 Prevalence of IFG and diabetes co-morbidity with other CVD risk factors across age groups
Age Group(years) | IFG co-morbidity with CVD risks | Diabetes co-morbidity with CVD risks | ||||||
|---|---|---|---|---|---|---|---|---|
| Â | IFG n (%) | IFG with dyslipidaemia n (%) | IFG with HBP n (%) | IFG with overweight/obese n (%) | Diabetes n (%) | Diabetes with dyslipidaemia n (%) | Diabetes with HBP n (%) | Diabetes with overweight/obese n (%) |
18-29 | 30 (5.3) | 24 (4.2) | 9 (1.6) | 11 (1.9) | 12 (2.1) | 11 (1.9) | 5 (0.9) | 8 (1.4) |
30-39 | 21 (4.2) | 19 (3.8) | 4 (0.8) | 13 (2.6) | 9 (1.8) | 8 (1.6) | 3 (0.6) | 5 (1.0) |
40-49 | 35 (6.9) | 29 (5.8) | 13 (2.6) | 19 (3.8) | 19 (3.8) | 16 (3.2) | 10 (2.0) | 12 (2.4) |
50-59 | 25 (5.8) | 23 (5.3) | 11 (2.6) | 17 (4.0) | 16 (3.7) | 13 (3.0) | 8 (1.9) | 10 (2.3) |
60-69 | 28 (8.0) | 25 (7.2) | 7 (2.0) | 15 (4.3) | 11 (3.2) | 9 (2.6) | 6 (1.7) | 10 (2.9) |
70-89 | 2 (2.1) | 2 (2.1) | 1 (1.1) | 1 (1.1) | 9 (9.6) | 8 (8.5) | 1 (1.1) | 3 (3.2) |
Total | 141 (5.8) | 122 (5.0) | 45 (1.8) | 76 (3.1) | 76 (3.1) | 65 (2.7) | 33 (1.3) | 48 (2.0) |